BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Napolitano M, D'amico F, Ragaini E, Peyrin-biroulet L, Danese S. Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy. DDDT 2022;Volume 16:1897-913. [DOI: 10.2147/dddt.s340459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Roskoski R Jr. Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacol Res 2022;183:106362. [PMID: 35878738 DOI: 10.1016/j.phrs.2022.106362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]